Shiming Zang
Papers
1
Total Citations
96
H-Index
1
About
Dr. Shiming Zang is a leading figure in oncologic imaging, with a focused expertise in prostate cancer diagnostics. His most cited work, a 2017 study with 96 citations, directly compares the efficacy of 68Ga-PSMA-11 PET-CT against multiparametric magnetic resonance imaging (mpMRI) for preoperative lymph node staging in intermediate- to high-risk prostate cancer patients. This landmark contribution provides critical, comparative data that helps clinicians choose the most accurate imaging modality for surgical planning, directly impacting patient management by improving the detection of nodal metastases prior to radical prostatectomy. Dr. Zang’s research sits at the intersection of nuclear medicine and radiology, advancing the precision of cancer staging. His work is highly influential, as evidenced by the sustained citation of his comparative study, which serves as a key reference for urologists and radiologists seeking to optimize the use of advanced imaging in prostate cancer care. Through rigorous retrospective analysis, Dr. Zang has helped clarify the diagnostic strengths of both PSMA PET-CT and mpMRI, solidifying his reputation as a vital contributor to evidence-based oncologic imaging.
Research Focus
Key Achievements
Top Papers
- 1